Member Info for JimiHendrix

Somebody clearly deploying desperate measures in a hope to scare people in to selling so they can buy back in lower. Yes these sells are likely the ii reducing their holding as expected, and also as expected they are quickly being bought up my the market and another ii. With the high possibility of fantastic news on several fronts over the coming days/weeks, it is way too risky trading this at the moment in my opinion. Best to hold or buy more in my opinion, though each to their own.

So in the USA until the FDA get to approving our test, people will only be able to take the test under medical supervision, not from home. However, could it still be used in drive through test centres where there is usually somebody there who explains how to do the test? I wonder if that counts as medical supervision.

“The FDA's definition of "Rx only" / "prescription only" is (approximately) "for provision and use only at a licensed physician's direction and under medical supervision".”

It depends on the stock, a lot of AIM stocks are unborrowable. I would think it’s because of the risk and volatility, you wouldn’t want to be shorting a stock that could easily and quite quickly rise hundreds of %.

Genedrive stock is unborrowable so it can’t be shorted.

And obviously ours will have vastly higher throughput compared to the usual kind of PCR test, up to 1000 processed per 8 hour day.

Our test is the PCR kind of test, which is much better for testing whether people have been infected (even before symptoms). Antigen tests are mainly used for detecting whether somebody no longer has the virus. So both kinds work well together. That’s my understanding anyway. Unlike other PCR tests ours requires much lower labour costs as it will be automated with BCs machines.

Yes sorry lol I was reposting something I had read on twitter which was removed after. Having had time to read the rns properly myself I can see the 63m is the total shares in issue. They have sold a few, and also the total shares in issue has increased a bit.

I think they've bought more, resulting situation is they have 63,282,548 shares which is about 100,000 more than on 2nd Feb.

Calculus have bought more shares.

Watch the BRR Media interview with Reabold from yesterday if anybody hasn't already. WN sounds huge! Oil and gas everywhere and even better than the A2 well drilled last year.

"if Wressle doesn't perform then Egdon can default and settle the debt with 25% of an underperforming asset" ...that's exactly the thing that has been troubling me with this loan. If Wressle turns out to be poor for any reason, then I doubt the 25% will be worth anything like a £1million. I also don't really see any reason to wait for the new year before starting, why not take the chance at get going with it asap? And if there does turn out to be any supply delays over christmas then so be it we wait.

2000000 and 2500000, must surely be buys at over 2p from around the end of the day, second trade at a higher price than the first.

That looks like a £40000 buy going by the price of the sell that came before it yesterday morning.

We don't know how many other companies were interested in the license, I can imagine quite a few would be interested given it's location! Being awarded this license through a grant system would mean they chose ECR based on several factors including ECR's experience, technical ability, projected plans etc ...it's not simply given to whoever offers the most money.

“moving forward to pre-clinical in vivo antibody production study for covid-19 as part of our proof of concept plans for @nuvec delivery system for wide range of vaccines #N4P” ....silly drop, good buying opportunity there.

This drop correlates with the drop in oil price. Seems to me the rumour was invented to exagerate this natural pullback, in order for people to load up on the cheap.

Delayed from earlier.

The date of the conference call made me suspicious about Brockham on top of all the other hints recently. One thing is clear, the BOD knew they weren’t going to flow test it long before they told the market.

I disagree... if this current drill is a success like the first then it should double the company’s income which will definitely positively affect the share price. The Spanish seismic result, if good, will send this up considerably imo. They’ll also have the option of selling Spain if they want or finding a partner before deciding on funding it themselves. Italy looks like it’s going to be fantastic.

I can’t see the 4p value of the gas field ever being reflected in the share price as that’s what it’s worth in income over 10 years. For instance if Angus were to sell it (once connected up) nobody is going to pay the equivalent 4p value (approx £20m) ... it would make no sense.